Sintilimab and Nimotuzumab Combined With Chemotherapy for the Treatment of R/M HNSCC.
Clinical trial NCT04882462 · UNKNOWN
Trial details
- NCT number
- NCT04882462
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-01
- Primary completion
- 2021-11-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.